Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MAI CDMO Network is a specialized platform and service provider that connects pharmaceutical and biotechnology companies with contract development and manufacturing organizations (CDMOs). Founded by Álvaro Marcé and Antonio Martínez, the company serves as a strategic partner to streamline the drug development process by facilitating efficient connections between drug developers and manufacturing solutions. The network focuses on a wide range of therapeutic modalities, including small molecules, biologics, and advanced bioconjugation techniques for antibody-drug conjugates (ADCs). By leveraging advanced tools and industry expertise, MAI CDMO Network aims to accelerate innovation and growth within the global pharmaceutical manufacturing ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Marcé.